amsacrine has been researched along with Atrial Fibrillation in 1 studies
Amsacrine: An aminoacridine derivative that intercalates into DNA and is used as an antineoplastic agent.
amsacrine : A sulfonamide that is N-phenylmethanesulfonamide substituted by a methoxy group at position 3 and an acridin-9-ylamino group at position 4. It exhibits antineoplastic activity.
Atrial Fibrillation: Abnormal cardiac rhythm that is characterized by rapid, uncoordinated firing of electrical impulses in the upper chambers of the heart (HEART ATRIA). In such case, blood cannot be effectively pumped into the lower chambers of the heart (HEART VENTRICLES). It is caused by abnormal impulse generation.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arlin, Z | 1 |
| Mehta, R | 1 |
| Feldman, E | 1 |
| Sullivan, P | 1 |
| Pucillo, A | 1 |
1 other study available for amsacrine and Atrial Fibrillation
| Article | Year |
|---|---|
Amsacrine treatment of patients with supraventricular arrhythmias and acute leukemia.
Topics: Acute Disease; Aged; Amsacrine; Arrhythmia, Sinus; Atrial Fibrillation; Female; Humans; Leukemia; Mi | 1987 |